Tilray Inc (NASDAQ:TLRY) Director Christine St.Clare sold 4,000 shares of the firm’s stock in a transaction dated Thursday, June 20th. The stock was sold at an average price of $50.01, for a total value of $200,040.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.
Shares of TLRY stock opened at $46.81 on Wednesday. The firm has a 50 day moving average of $43.44. The company has a debt-to-equity ratio of 1.13, a current ratio of 2.35 and a quick ratio of 2.06. Tilray Inc has a twelve month low of $20.10 and a twelve month high of $300.00. The company has a market cap of $4.55 billion and a P/E ratio of -57.09.
Tilray (NASDAQ:TLRY) last issued its quarterly earnings data on Tuesday, May 14th. The company reported ($0.27) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.25) by ($0.02). Tilray had a negative net margin of 159.09% and a negative return on equity of 43.71%. The company had revenue of $23.00 million during the quarter, compared to the consensus estimate of $20.50 million. Tilray’s revenue for the quarter was up 194.9% on a year-over-year basis. Sell-side analysts predict that Tilray Inc will post -0.89 earnings per share for the current fiscal year.
Several hedge funds have recently modified their holdings of TLRY. Lee Financial Co bought a new position in shares of Tilray in the 1st quarter valued at approximately $25,000. Quantamental Technologies LLC bought a new position in shares of Tilray in the 1st quarter valued at approximately $26,000. Toronto Dominion Bank bought a new position in shares of Tilray in the 4th quarter valued at approximately $27,000. PNC Financial Services Group Inc. raised its stake in shares of Tilray by 105.8% in the 1st quarter. PNC Financial Services Group Inc. now owns 463 shares of the company’s stock valued at $30,000 after acquiring an additional 238 shares in the last quarter. Finally, Synovus Financial Corp grew its holdings in Tilray by 2,500.0% in the 1st quarter. Synovus Financial Corp now owns 1,040 shares of the company’s stock valued at $69,000 after buying an additional 1,000 shares during the last quarter. 2.10% of the stock is currently owned by institutional investors and hedge funds.
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.
Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.